Keyphrases
Retina
100%
Visual Acuity
71%
Israel
61%
Bevacizumab
61%
Age-related Macular Degeneration
60%
Myopic Choroidal Neovascularization (mCNV)
60%
Cone Size
59%
Retinal Degeneration
54%
Cataract Surgery
54%
Retinal Toxicity
52%
Spectral Domain Optical Coherence Tomography (SD-OCT)
49%
Retinal Function
42%
Intravitreal Ranibizumab
41%
Inherited Retinal Degeneration
41%
Adaptive Optics Ophthalmoscopy
40%
Endophthalmitis
40%
Genetic Analysis
38%
Israeli
36%
Topical Bevacizumab
36%
Inherited Retinal Disease
36%
Neovascular Age-related Macular Degeneration (nAMD)
36%
Electroretinography
36%
Cataract
35%
Best-corrected Visual Acuity
33%
Retinal Dysfunction
32%
Grader
32%
Intravitreal Injection
31%
Intravitreal Administration
31%
Glial Fibrillary Acidic Protein
31%
Retinitis pigmentosa
31%
Albino Rabbit
30%
Ophthalmic Examination
30%
Retinal pigment Epithelium
30%
FAM161A
29%
Hyperoxaluria
29%
Ophthalmology
27%
Retinal Structure
27%
Autosomal Dominant Retinitis pigmentosa
27%
Electroretinogram
27%
Crystallin
25%
Intraocular Pressure
25%
Drusen
25%
Optical Coherence Tomography Images
24%
High Dose
24%
Macular
23%
Cone Structure
23%
Retinopathy
23%
Oligomeric
22%
Rabbit Retina
21%
Retina Specialists
21%
Medicine and Dentistry
Visual Acuity
72%
Age Related Macular Degeneration
70%
Choroidal Neovascularization
64%
Retina Degeneration
54%
Cataract Surgery
54%
Endophthalmitis
54%
Intravitreal Administration
53%
Spectral Domain Optical Coherence Tomography
48%
Electroretinography
39%
Ophthalmology
39%
Retinal Detachment
38%
Prevalence
38%
Retinitis pigmentosa
38%
Scanning Laser Ophthalmoscopy
37%
Medicine
36%
Retinal Pigment Epithelium
36%
Bevacizumab
36%
Best Corrected Visual Acuity
33%
Agents Acting on the Eye
33%
Fibril
28%
Angiography
27%
Cataract
27%
Retina Disease
26%
Vitreous
25%
Intraocular Pressure
23%
Amyloid Protein
22%
Primary Hyperoxaluria
21%
Diseases
21%
Retinopathy
21%
Retina Macula Cystoid Edema
19%
Outer Nuclear Layer
19%
Ex Vivo
19%
Oxalic Acid
19%
Drusen
19%
Optical Coherence Tomography
18%
In Vitro
18%
Awareness
18%
Penetrance
18%
Contact Lens
18%
Ethnic Disparity
18%
Newborn Period
18%
Home Monitoring
18%
Calgranulin B
18%
In Vitro Toxicity
18%
Neonate
18%
Autosomal Dominant Inheritance
18%
Wet Macular Degeneration
18%
Geographic Atrophy
18%
Odds Ratio
18%
Gender Bias
18%